December 4, 2015
TLipo Escultura and JAT Natural Corp recalling all Lipo Escultura
The FDA has informed that TLipo Escultura Corp. of Brooklyn, NY dba JAT Productos Naturales Corp., and JAT Natural Products…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
December 4, 2015
Lilly quits developing basal insulin peglispro
Eli Lilly and Company will cease development of basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, in order to focus research and development efforts on other assets in its portfolio and pipeline.
December 4, 2015
Genomic Vision partners up with the University-Hospital Institute (IHU) Imagine
Genomic Vision – has signed a strategic partnership with the University-Hospital Institute (IHU) Imagine, the largest European genetic research and care cluster.
December 4, 2015
MaSTherCell will fabricate TxCell’s ASTrIA platform products in Europe
TxCell SA has signed a 5-year agreement with MaSTherCell, a Contract Manufacturing Organization (CMO), based in Belgium.
According to this agreement, MaSTherCell will be the exclusive manufacturer in Europe of all products from TxCell’s ASTrIA platform.
December 4, 2015
India’s Sun Pharmaceutical enters $2.5B US market with its generic version of Gleevec
Sun Pharmaceutical Industries, largest India-based generic pharmaceutical companies, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Novartis’ Gleevec.
December 3, 2015
Anavex appoints Preclinical Operations vice president
Anavex has appointed Ulrich Elben, PhD as Vice President of Preclinical Operations, who will be responsible for the pipeline development and optimization.
December 3, 2015
Adgenix to distribute Premaitha Health’s prenatal screening test Iona in France
Premaitha Health said Wednesday that Adgenix has already signed up its first laboratory customer for Premaitha in France, with a signed contract for a minimum of three years to supply LaboSud with the Iona test.
December 2, 2015
Flood in Chennai suspends operations at Natco Pharma API plant (India)
Flood in India’s Chennai suspends operations at Natco Pharma API plant
December 1, 2015
Savy Akers’ production facility in China fully operational
Savy Akers’ 10,000 square foot production facility in Haikou National Hi-Tech Industrial Zone, Hainan province, is now fully operational.
December 1, 2015
Horizon Pharma gets additional notice of allowance with claims covering Pennsaid 2%
Horizon Pharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number entitled “Treatment of Pain with Topical Diclofenac” for a drug Pennsaid 2% w/w.